XML 38 R26.htm IDEA: XBRL DOCUMENT v3.24.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities Excluded from Earnings Per Share

  

Potentially Dilutive Security  Quantity   Stated Value Per Share   Total Value or Stated Value   Assumed Conversion Price   Resulting Common Shares 
Merger Options, restricted stock units, and performance stock units (1)   9,050,909   $   $   $    1,050,909 
Common stock warrants   228,004,372                9,064,951 
Series D Preferred Stock   14,457    1,000    14,456,680    5.00    2,891,336 
Senior Convertible Note (2)           15,750,000    7.79    2,021,823 
                          
Total   -    -    -    -    15,029,018 

 

(1) Not exercisable or vested as of September 30, 2024. Refer to Note 13 – Common Stock Options and Warrants for a discussion of the Merger Options (defined herein) and Note 14 – Long–Term Incentive Compensation for a discussion of the restricted stock units and performance stock units.
(2) Reflects the conversion option of the $15.0 million Senior Convertible Note at 105% principal amount, pursuant to the SEPA. Refer to Note 8 – Debt for a discussion of the Senior Convertible Note and Note 12 – Common Stock for a discussion of the SEPA.

 

The following table presents the potentially dilutive securities which were not included in the computation of diluted earnings (loss) attributable to common stockholders for the three and nine months ended September 30, 2023 because their inclusion would be anti–dilutive:

 

Potentially Dilutive Security  Quantity   Stated Value Per Share   Total Value or Stated Value   Assumed Conversion Price   Resulting Common Shares 
Common stock options and restricted stock units (1)   8,641,176   $   $   $    641,176 
Common stock warrants   447,855,367                15,674,938 
AR Debentures           2,000,000    5.00    400,000 
Series D Preferred Stock   21,799    1,000    21,799,000    5.00    4,359,850 
Series E Preferred Stock   20,000    1,000    20,000,000    5.00    4,000,000 
                          
Total   -    -    -    -    25,075,964 

 

(1) Not exercisable or vested as of September 30, 2023. Refer to Note 13 – Common Stock Options and Warrants for a discussion of the Merger Options and Note 14 – Long–Term Incentive Compensation for a discussion of the restricted stock units.
Schedule of Non-cash Investing And Financing Activities And Supplemental Cash Flow Disclosures

The following table presents non–cash investing and financing activities and supplemental cash flow disclosures relating to the cash paid for interest and income taxes for the periods presented:

 

Schedule of Non-cash Investing And Financing Activities And Supplemental Cash Flow Disclosures 

         
   Nine Months Ended September 30, 
   2024   2023 
Non–cash investing and financing activities:          
Common Stock issued upon conversion of Series D Preferred Stock  $6,170,450   $ 
Common Stock issued upon conversion of Series E Preferred Stock  $20,000,000   $ 
Capital expenditures included in accrued liabilities  $

(4,717,644

)  $ 
Proceeds from Senior Convertible Note issuance not yet received, net of original issuance discount (1)  $14,250,000   $ 
Proceeds from Subordinated Note issuance not yet received – related party(1)  $2,000,000   $ 
Common Stock issued for SEPA commitment fee (2)  $600,000   $ 
Cryptocurrency mining equipment and deposits acquired in the Merger  $   $20,760,560 
Secured convertible debentures assumed in the Merger  $   $1,981,000 
SBA loan payable acquired assumed in the Merger  $   $150,000 
Membership interests converted into shares of Common Stock  $   $(606,705)
Common Stock issued at Merger  $   $9,928,262 
Series D Preferred Stock issued at Merger  $   $3,209,196 
Common Stock and warrants issued in Exok option acquisition  $   $7,289,492 
Common Stock issued in satisfaction of share issuance obligation  $   $2,006,741 
Deferred transaction costs capitalized to oil and natural gas properties  $   $189,031 
Deferred transaction costs associated with financing  $   $519,533 
Supplemental disclosure:          
Cash paid for income taxes  $   $ 
Cash paid for interest  $   $57,101 

 

(1) Proceeds from the issuance of the Senior Convertible Note and the Subordinated Note were not received until October 1, 2024. Therefore, the Company recorded the unreceived proceeds as Financing receivable as of September 30, 2024. Refer to Note 8 – Debt for a discussion of the Senior Convertible Note and the Subordinated Note.
(2) Pursuant to the SEPA, the Company issued 100,000 shares to Yorkville as a commitment fee. Refer to Note 12 – Common Stock for a discussion of the SEPA.